Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+27.1%
5Y CAGR+9.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+27.1%/yr
Annual compound
5Y CAGR
+9.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.39 | +67.3% |
| 2024 | 3.22 | +15.1% |
| 2023 | 2.80 | +6.7% |
| 2022 | 2.62 | -39.9% |
| 2021 | 4.36 | +24.5% |
| 2020 | 3.50 | +32.1% |
| 2019 | 2.65 | +162.1% |
| 2018 | -4.27 | +39.4% |
| 2017 | -7.05 | +71.3% |
| 2016 | -24.57 | - |